Radiology – Neurology
Review: Endovascular Management of Acute Stroke
20 Oct, 2024 | 14:43h | UTCIntroduction: Stroke due to large vessel occlusion (LVO) remains a leading cause of disability and mortality worldwide. Endovascular therapy has revolutionized acute ischemic stroke management by enhancing recanalization rates and improving patient outcomes. This review outlines the evolution of endovascular treatments, expansion of therapeutic indications, current best practices, and ongoing research in the endovascular management of acute stroke.
Key Recommendations:
- Early Time Window Therapy (0–6 Hours): Robust evidence from randomized controlled trials demonstrates that mechanical thrombectomy significantly improves functional outcomes in patients with anterior circulation LVO presenting within 6 hours of symptom onset. Patients are selected based on moderate-to-severe neurological deficits and small infarct cores identified via imaging.
- Extended Time Window Therapy (6–24 Hours): Trials such as DAWN and DEFUSE3 have extended thrombectomy benefits to patients up to 24 hours after symptom onset. Advanced imaging techniques, like CT perfusion and MRI, identify patients with substantial penumbral tissue, indicating potential for recovery.
- Large Ischemic Core Infarcts: Recent studies (e.g., SELECT2, ANGEL-ASPECT) suggest that patients with large core infarcts can benefit from endovascular therapy, challenging previous contraindications. Individualized patient selection is crucial to balance risks and benefits.
- Basilar Artery Occlusion: New evidence supports thrombectomy for basilar artery occlusions, especially in patients with moderate-to-severe symptoms. This intervention improves outcomes in a condition historically associated with high morbidity and mortality.
- Bridging Thrombolysis: The necessity of intravenous thrombolysis before thrombectomy in patients directly admitted to endovascular centers is under debate. Meta-analyses indicate that omitting thrombolysis may not adversely affect outcomes, although it remains standard for patients at non-thrombectomy centers.
- Simplified Imaging for Patient Selection: The use of non-contrast CT and CT angiography alone has proven effective for patient selection, reducing treatment delays and expanding access to thrombectomy, particularly in resource-limited settings.
Conclusion: Advancements in endovascular therapy have markedly improved outcomes for patients with acute ischemic stroke due to LVO. Expanded treatment indications and simplified imaging protocols have broadened patient eligibility for thrombectomy. Ongoing research into adjunctive therapies and optimization of management strategies holds promise for further reducing stroke-related disability and mortality.
Cohort Study: One-Fourth of MS Relapses Occur Without MRI Activity, Highlighting ACES Phenomenon – JAMA Neurol
18 Aug, 2024 | 19:16h | UTCStudy Design and Population: This multicenter observational cohort study examined 637 clinical relapse events in 608 patients with relapsing-remitting multiple sclerosis (RRMS) from the French MS registry, spanning January 2015 to June 2023. The study included relapses with brain and spinal cord MRI performed within 12-24 months before and 50 days after the event.
Main Findings: Approximately 26% of relapses were classified as acute clinical events with stable MRI (ACES), showing no new T2 or gadolinium-enhanced T1 lesions. ACES were more likely in patients on highly effective disease-modifying therapies (DMTs), with longer disease duration, or with fatigue. ACES were associated with increased rates of relapse, confirmed disability accrual, and progression to secondary progressive MS, though their MRI stability was unaffected by DMTs.
Implications for Practice: The study suggests that MRI alone may not fully capture disease activity in RRMS, highlighting the need for comprehensive clinical assessment in therapeutic decision-making and clinical trial designs.
Cohort Study: Efficacy of first-line color doppler ultrasound in diagnosing giant cell arteritis – Ann Intern Med
25 May, 2024 | 19:39h | UTCThis prospective multicenter study aimed to evaluate the efficacy of using color Doppler ultrasound of the temporal arteries as the first-line diagnostic tool for Giant Cell Arteritis (GCA) in 165 elderly patients with high clinical suspicion of the disease. The study followed participants over two years, comparing ultrasound results with temporal artery biopsy (TAB) and physician-based clinical diagnosis including other imaging tests. Key findings indicate that ultrasound confirmed GCA in 44% of cases, which was higher compared to TAB (17%) and clinical expertise (21%). The study showed that using ultrasound first can avoid the need for further invasive tests like TAB in patients with positive ultrasound results. The limitations of the study include its small sample size, unblinded test results, and the absence of a universally accepted objective diagnostic standard. However, it highlights the potential of ultrasound in the early and non-invasive diagnosis of GCA, potentially reducing the risk of severe complications by expediting treatment initiation.
Reference (link to abstract – $ for full-text):
RCT | Endovascular treatment vs. no treatment after 6-24h in ischemic stroke patients with collateral flow on CT angiography
5 Apr, 2023 | 13:38h | UTCEndovascular treatment versus no endovascular treatment after 6–24 h in patients with ischaemic stroke and collateral flow on CT angiography (MR CLEAN-LATE) in the Netherlands: a multicentre, open-label, blinded-endpoint, randomised, controlled, phase 3 trial – The Lancet (link to abstract – $ for full-text)
Applying AI to MRI | A promising approach for detecting severe mental illness risk
4 Apr, 2023 | 13:25h | UTC
Cohort Study | Long-term changes in the size of pituitary microadenomas
3 Mar, 2023 | 13:49h | UTCSummary: The prevalence of pituitary lesions in radiologic studies is estimated to be 10% to 38.5%. However, it is unclear how frequently incidental lesions should be monitored by serial pituitary MRI. A retrospective longitudinal cohort study was conducted to evaluate changes in pituitary microadenomas over time. During the study period (from 2003 to 2021), 414 patients with pituitary microadenomas were identified, and 177 patients had more than 1 MRI. Approximately two-thirds of the microadenomas demonstrated no change or a decrease in size, while the rest exhibited a slow growth rate, indicating that less frequent monitoring could be considered safe.
Article: Long-Term Changes in the Size of Pituitary Microadenomas – Annals of Internal Medicine (link to abstract – $ for full-text)
News Release: Fewer surveillance MRIs may be appropriate for patients with incidental pituitary lesions – American College of Physicians
Commentary on Twitter
New from @harvardmed: new study suggests that less frequent pituitary #MRI surveillance for patients with incidental pituitary #microadenomas may be safe: https://t.co/w4hzk8ISQq pic.twitter.com/2MeK14SRph
— Annals of Int Med (@AnnalsofIM) February 28, 2023
Consensus Paper | Use of cerebral CT angiography to support a clinical diagnosis of death using neurological criteria
10 Feb, 2023 | 13:48h | UTC
Review | Brain enlarged perivascular spaces as imaging biomarkers of cerebrovascular disease
31 Jan, 2023 | 13:37h | UTC
Commentary on Twitter
Brain Enlarged Perivascular Spaces as Imaging Biomarkers of Cerebrovascular Disease: A Clinical Narrative Review #AHAJournals https://t.co/3MF2yEAvjA
— JAHA (@JAHA_AHA) December 23, 2022
Cohort Study | Brain cancer after radiation exposure from CT examinations of children and young adults
18 Jan, 2023 | 14:36h | UTCBrain cancer after radiation exposure from CT examinations of children and young adults: results from the EPI-CT cohort study – The Lancet Oncology (link to abstract – $ for full-text)
Commentaries:
CT brain cancer risk quantified for children and young adults – medwire News
Review | Multimodality imaging of neurodegenerative disorders with a focus on multiparametric magnetic resonance and molecular imaging
18 Jan, 2023 | 14:11h | UTC
Review | Safety and management of implanted epilepsy devices for imaging and surgery.
27 Nov, 2022 | 22:03h | UTC
M-A | Use of CT of the head in patients with acute atraumatic altered mental status.
22 Nov, 2022 | 13:38h | UTC
Commentary on Twitter
Meta-analysis: 94% of patients with atraumatic altered mental status received a noncontrast CT head, with an average yield of 11% which varied by setting: 18% in ED patients, 12% of ICU patients, and 3% of general inpatients had positive findings on CT. https://t.co/yHWj6uSwTM
— JAMA Network Open (@JAMANetworkOpen) November 18, 2022
Consensus Paper | State-of-the-art CT and MR imaging and assessment of atherosclerotic carotid artery disease.
7 Nov, 2022 | 12:44h | UTC
Cohort Study | Clinical diagnosis and magnetic resonance imaging in patients with transient and minor neurological symptoms.
31 Oct, 2022 | 13:31h | UTC
Commentary on Twitter
Clinical Diagnosis and Magnetic Resonance Imaging in Patients With Transient and Minor Neurological Symptoms: A Prospective Cohort Study https://t.co/8S9zWuBRYe @mattreed73 @edinburghstroke @EdinUniBrainSci @bleedingstroke @emerge_research @strokeblokeFAST @EdinUniNeuroImg pic.twitter.com/5wjWZS8YwH
— Stroke AHA/ASA (@StrokeAHA_ASA) August 9, 2022
Cohort study | MRI visible perivascular spaces and risk of incident dementia.
27 Oct, 2022 | 12:25h | UTC
Commentary on Twitter
This study investigates the association between MRI-visible perivascular space burden and the risk of incident #dementia. https://t.co/TsuZqtQhFp #Neurology #NeuroTwitter pic.twitter.com/mpvthiqznp
— Neurology Journal (@GreenJournal) October 9, 2022
Differentiating multiple sclerosis from AQP4-neuromyelitis optica spectrum disorder and MOG-antibody disease with imaging.
26 Oct, 2022 | 14:24h | UTC
Commentary on Twitter
Published online: Cortese @RosaCortese5 and colleagues assessed whether imaging characteristics typical of multiple sclerosis (#MS) discriminate relapsing remitting MS from AQP4-NMOSD and #MOGAD, alone and in combination. Learn more: https://t.co/AWYoEZQDP9 #NeuroTwitter pic.twitter.com/3Pytn45uLx
— Neurology Journal (@GreenJournal) October 12, 2022
Cohort Study | Carotid plaque characteristics predict recurrent ischemic stroke and transient ischemic attack.
14 Oct, 2022 | 14:08h | UTC
Radiological assessment of dementia | Consensus for a practical and clinically oriented guide to image acquisition, evaluation, and reporting.
13 Sep, 2022 | 13:13h | UTC
European recommendations on practices in pediatric neuroradiology.
6 Sep, 2022 | 14:33h | UTC
Systematic Review | Duplex ultrasound for diagnosing symptomatic carotid stenosis in the extracranial segments.
1 Sep, 2022 | 11:36h | UTC
Review | Role of imaging in CNS infections.
9 Aug, 2022 | 12:26h | UTCRole of imaging in CNS infections – Indian Journal of Pathology & Microbiology
Consensus on magnetic resonance imaging of endolymphatic hydrops in patients with suspected hydropic ear disease (Meniere).
26 Jul, 2022 | 12:40h | UTCEditorial: Editorial: Hydropic Ear Disease: Imaging and Functional Evaluation – Frontiers in Surgery
Commentary: Guidance Issued for MR Imaging of Endolymphatic Hydrops – HealthDay
Brain volume abnormalities and clinical outcomes following pediatric traumatic brain injury.
15 Jul, 2022 | 12:41h | UTCBrain volume abnormalities and clinical outcomes following paediatric traumatic brain injury – Brain
News Release: Head injuries in children linked to reduced brain size and learning difficulties – Imperial College London
Commentary: Experts use MRI to pinpoint link between pediatric TBI and cognitive impairment – Health Imaging
Commentary on Twitter
Bourke et al. identify paediatric brain injury patients with low brain volume for their age and associated cognitive difficulties by generating age norms from over 1,200 healthy paediatric controls. https://t.co/N06ELchNPd pic.twitter.com/ouDU1kTYPT
— Brain (@Brain1878) July 8, 2022
Retrospective Cohort Study | Magnetic resonance imaging prognostic findings for visual and mortality outcomes in acute invasive fungal rhinosinusitis.
6 Jul, 2022 | 11:16h | UTCPortable, low-field magnetic resonance imaging enables highly accessible and dynamic bedside evaluation of ischemic stroke.
24 Jun, 2022 | 10:48h | UTCCommentary: Can Low-field Portable MRI Widen Access to Rapid Screening for Stroke? – Neurology Today